Malladi is a leader in Ephedrine, Pseudoephedrine Salts & Phenylephrine HCl // USFDA, EDQM, ANSM, KFDA, and TGA inspected.
01 1Malladi Drugs & Pharmaceuticals Limited
02 1Ami Lifesciences Private Limited
03 1Asahi Kasei Finechem Co., Ltd.
04 1Changzhou Yinsheng Pharmaceutical Co. Ltd.
05 1DARMERICA, LLC
06 1Fagron Inc
07 1Hunan Dongting Pharmaceutical Co., Ltd
08 1Kyowa Pharma Chemical Co., Ltd.
09 1LETCO MEDICAL, LLC
10 2Medisca Inc.
11 1Professional Compounding Centers of America dba PCCA
12 2SHILPA PHARMA LIFESCIENCES LIMITED
13 1Spectrum Laboratory Products, Inc.
14 1Zhejiang Bamboo Pharmaceuticals Co.,Ltd
01 2TRANEXAMIC ACID
02 13Tranexamic Acid
03 1Tranexamic acid
01 3China
02 4India
03 2Japan
04 1Netherlands
05 5U.S.A
06 1United Kingdom
Malladi is a leader in Ephedrine, Pseudoephedrine Salts & Phenylephrine HCl // USFDA, EDQM, ANSM, KFDA, and TGA inspected.
NDC Package Code : 57218-951
Start Marketing Date : 2020-12-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
AMI Lifesciences is Driven by Chemistry. Powered by People.
NDC Package Code : 59680-012
Start Marketing Date : 2023-07-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12848-1004
Start Marketing Date : 1972-04-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 47554-001
Start Marketing Date : 2011-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51552-0513
Start Marketing Date : 2004-09-01
End Marketing Date : 2027-05-27
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 12079-2001
Start Marketing Date : 2011-10-12
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-2794
Start Marketing Date : 2015-05-26
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 38779-3211
Start Marketing Date : 2020-02-20
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-0022
Start Marketing Date : 2014-06-06
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 49452-7876
Start Marketing Date : 2019-11-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
A CAS-1197-18-8 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CAS-1197-18-8, including repackagers and relabelers. The FDA regulates CAS-1197-18-8 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CAS-1197-18-8 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of CAS-1197-18-8 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A CAS-1197-18-8 supplier is an individual or a company that provides CAS-1197-18-8 active pharmaceutical ingredient (API) or CAS-1197-18-8 finished formulations upon request. The CAS-1197-18-8 suppliers may include CAS-1197-18-8 API manufacturers, exporters, distributors and traders.
click here to find a list of CAS-1197-18-8 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing CAS-1197-18-8 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for CAS-1197-18-8 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture CAS-1197-18-8 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain CAS-1197-18-8 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a CAS-1197-18-8 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of CAS-1197-18-8 suppliers with NDC on PharmaCompass.
We have 14 companies offering CAS-1197-18-8
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
